Research Project

Project Title:

Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD (PASS)

Project Type:

Observational Study, Enrolment ongoing

Disease group(s):

AD structural kidney disorders

Project Summary:

The purpose of this study is to evaluate the safety and effectiveness of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) in the real world clinical setting in Japan.

Lead principal investigator(s):

Bertrand Knebelmann, Paris

Project Period:

12/2017   -   03/2022

Sponsors:

Industry

ClinicalTrials.gov:

NCT02847624

« Back to research page